Publikationen von Patricia Priegue

Ghosh, C.; Priegue, P.; Leelayuwapan,, H.; Fuchsberger, F. F.; Rademacher, C.; Seeberger, P. H.: Synthetic glyconanoparticles modulate innate immunity but not the complement system. ACS applied bio materials 5 (5), S. 2185 - 2192 (2022)

Kaplonek, P.; Yao, L.; Reppe, K.; Voß, F.; Kohler, T.; Ebner, F.; Schäfer, A.; Blohm, U.; Priegue, P.; Bräutigam, M. et al.; Pereira, C. L.; Parameswarappa, S. G.; Emmadi, M.; Ménová, P.; Witzenrath, M.; Hammerschmidt, S.; Hartmann, S.; Sander, L. E.; Seeberger, P. H.: A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine (2022)

Sianturi, J.; Priegue, P.; Hu, J.; Yin, J.; Seeberger, P. H.: Semi-synthetic glycoconjugate vaccine lead against Acinetobacter baumannii 17978. Angewandte Chemie International Edition 61 (41), e202209556 (2022)

Zhang, S.; Sella, M.; Sianturi, J.; Priegue, P.; Shen, D.; Seeberger, P. H.: Discovery of oligosaccharide antigens for semi-synthetic glycoconjugate vaccine leads against Streptococcus suis serotypes 2, 3, 9 and 14. Angewandte Chemie International Edition 60 (26), S. 14679 - 14692 (2021)

Varela-Aramburu, S.; Ghosh, C.; Goerdeler, F.; Priegue, P.; Moscovitz, O.; Seeberger, P. H.: Targeting and inhibiting Plasmodium falciparum using ultra-small gold nanoparticles. ACS Applied Materials and Interfaces 12 (39), S. 43380 - 43387 (2020)